Niki BioSolutions, Inc. (NIKI) Consolidated Net Income (2024 - 2025)
Niki BioSolutions' (NIKI) quarterly Consolidated Net Income came in at $327410.0 in Q4 2025, up 408.13% YoY from $64434.3 in Q4 2024, and up 157.6% on a QoQ basis from -$568401.0 in Q3 2025.
Niki BioSolutions, Inc. (NIKI) Consolidated Net Income (2024 - 2025) Analysis & Trends
Niki BioSolutions (NIKI) has 2 years of Consolidated Net Income data on file, last reported at $327410.0 in Q4 2025.
- Quarterly Consolidated Net Income rose 408.13% year-over-year to $327410.0 in Q4 2025, while the trailing twelve-month figure through Nov 2025 was -$6654.0 (up 97.64% YoY) and the FY2025 annual result came in at -$743235.0, down 20.97% from the prior year.
- Consolidated Net Income rose to $327410.0 in Q4 2025, from -$568401.0 in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of $340594.0 in Q2 2025 to a low of -$568401.0 in Q3 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | 327,410.00 |
| Aug 31, 2025 | -568,401.00 |
| May 31, 2025 | 340,594.00 |
| Nov 30, 2024 | -106,257.00 |
| Aug 31, 2024 | -176,275.00 |